Our results show that most of the genes are negatively correlated with these drugs (based on IC50 values) between high- and low-risk groups in each tumor except for RBFOX2 in some tumors, YTHDF1 in SKCM and LUAD, FTO in LUSC and TGCT, and FMR1 in OV and UCS (Supplementary Figure S11). This evidence concerns the gene YTHDF1 and neoplasm.